Singapore, 7 May 2026 – Personalised risk-based monitoring may soon be the norm for patients with diabetes at high-risk of lower extremity amputation (LEA). Jointly developed by Singapore General ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results